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ADULT mice of several strains have been shown consistently to develop lung
adenomas as well as liver-cell tumours and hepatic haemangioendotheliomas
after exposure to dimethylnitrosamine (DMN) (Takayama and Oota, 1963 and
1965; Toth, Magee and Shubik, 1964). Renal tumours were less commonly
seen, i.e. in 2 of 87 BALB/c mice (Toth et al., 1964), in 3 of 60 ddN, 1 of 28 ICR
and 4 of 25 C3H mice (Takayama and Oota, 1963, and 1965). BALB/c mice
given single doses of DMN when newborn developed lung adenomas and liver-cell
tumours later in their life (Toth et al., 1964). The present report describes the
carcinogenicity of DMN in adult and newborn random bred Swiss mice. Liver
and lung tumours were observed in all the experimental groups; mice treated
when adult also developed renal adenomas. Tubular cysts were found in the
kidnevs of both experimental and untreated mice.
MATERIAL AND METHODS
A total of 143 experimental mice and 69 untreated controls of both sexes were
used. The animals were random-bred Swiss mice of a colony obtained in 1961
from the Division of Oncology, The Chicago Medical School, and subsequently
bred in this laboratory. In the first two experiments, 5-6 weeks old mice were
given DMN (Eastman Organic Chemicals) in the drinking water. The bottles
were prepared every second day from a stock 0.1% solution which was renewed
weeklv. In experiment I, in which the concentration of DMN in the drinking
water was 0-0050, the treatment was stopped after a week because of its acute
toxicity. particularly among males. In experiment II, the original concentration
of 0.0025% also proved to be acutely toxic and was discontinued after 3 weeks;
two weeks later the treatment was resumed at a concentration of 0-0005 00 and
lasted a further 35 weeks. In experiments IIr and IV respectively less than
24 hours old and 7 days old mice received a subcutaneous injection of25 or 37-5 ptg.
of DMN as 0-050% solution in distilled water. Animals showing leakage at with-
drawal of the syringe were discarded. Survivors were weaned at 4 weeks of age.
The animals of all the groups were housed in groups of 5-10 in plastic cages on
sawdust and fed Valleolona diet for mice in pellets. The mice were allowed to
die naturally or were killed when moribund. Complete autopsy was regularly
performed. except for a mouse from experiment III which was cannibalized.
Histological sections were prepared from lungs, liver and kidneys in all the
animals. as well as from other organs if grossly damaged. But for a few excep-
tions, at least a coronary section from each kidney was studied histologically.
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RESULTS
The experimental plan, survival rates, incidence and latent periods of the
main types of tumours are presented in Table I. In each group, for each type of
tumour the incidence is reported as tumour bearing animals/survivors at the
time of death (or killing) of the first animal with that type of tumour.
It is obvious that the lifespan of the experimental animals was shortened.
Those dying early during or after the treatment showed liver damage, as commonly
seen during acute intoxication with DMN (Barnes and Magee, 1954). From the
30th week onwards the main causes of death were respiratory insufficiency
produced by the great number of lung adenomas and/or peritoneal bleeding in
mice with liver haemorrhagic lesions.
In groups I and II at autopsy all the animals but one at risk showed lunlg
adenomas. These were more than 15 per animal, up to 1 cm. in diameter. occasion-
ally necrotic and in a few cases quite anaplastic. Lung adenomas were seen in
16 out of 25 animals in group III and in all the 14 mice at risk ofgroup IV. Their
number varied between 5 and 15. The two mice of each sex developing lung
tumours among the untreated controls had less than 5 adenomas per aniimal.
Liver tumours were seen in all the experimental groups. The most commonl
types of liver tumours were angiomas and angiosarcomas among mice treated
when adult (Fig. 1) and hepatomas in animals injected at birth (Fig. 2). In
fact, considering together groups I and II, 16 mice had vascular tumours and
only 5 developed liver-cell tumours, whereas in groups III and IV considered
together the number of animals developing each type of liver tumour were respec-
tively 1 and 23. In addition, in groups I and II, haemorrhagic cysts in the liver
were seen in 12 mice, 6 ofwhich had no liver tumours. The criteria for distinguish-
ing between haemorrhagic cysts, angiomas and angiosarcomas were those described
by Toth et al. (1964). However, in Table I, benign and malignant vascular
tumours have been considered together. Diffuse proliferation of Kupffer's cells
was also seen in some mice. In groups III and IV liver tumours were mainly
trabecular hepatomas, up to 1P5 cm. in diameter, often multiple. Lung meta-
stases were seen in one case. Hyperplastic nodules were only occasionally seen.
Renal tumours were found in a total of 17 mice treated with DMN wheni
adult, even for a week only. They reached a diameter of 2-3 mm. and were
either cystic-papillary or solid adenomas. Although in a few instances minor
nuclear irregularities were present, no atypicalities, invasion, metastases or other
EXPLANATION OF PLATES
FIG. 1.--Experiment II. Male killed at the 49th week. Angioma of the liver dissociatiing liver
cords. x 110.
FIG. 2.-Experiment IV. Female killed at the 61st week. Trabecular hepatoma of the liver.
Borderline with preserved liver parenchyma. x 110.
FIG. 3.-Experiment II. Male dying at the 42nd week. Papillary adenoma of the kidney.
Compression of surrounding parenchyma. x 75.
FIG. 4. Experiment I. Female killed at the 58th week. Two adjacent renal adenomas
containing desquamating cells and showing papillary proliferation. Some nuclear irregulari-
ties. x 110.
FIG. 5. Control female killed at the 104th week. Dilated renal tubule lined by large epithelial
cells with slight nuclear irregularities. x 280.
FiG. 6. Experiment IV. Male mouse dying at the 61st week. Tubular cyst in the kidney
showing a few papillae. Epithelial cells are regular. x 110.BRITISH JOLURNAL OF CANCER.
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signs of malignancy were seen. The surrounding parenchyma was compressed
(Fig. 3 and 4). Among the animals of groups III and IV and in the untreated
controls no renal adenomas were seen. In addition, dilated renal tubules lined
bv large epithelial cells with typical nuclei or mild irregularities were found in
mice observed after the 32nd week in all the groups, including the untreated
controls. On occasions the cells were piled up in 2-3 layers or formed a few
short papillae. These lesions were usually recognized only histologically and
were considered as a morphological entity distinct from the adenomas by virtue
of their small size, the lack of compression of the surrounding renal parenchyma
and the paucity of papillary proliferation (Fig. 5 and 6). Cysts of this type
were observed in 5 females in group I, 3 of which had also renal adenomas; in
6 females and 7 males in group II (3 and 1 respectively with renal tumour); in
2 females in group III, in 2 females and 1 male in group IV and in 7 females and
3 males in the control group.
DISCUSSION
The pattern of liver carcinogenesis observed in the present experiments is
similar to that described in previous work on the effects of DMN on other strains
of mice as well as in experiments in which the related compound diethylnitro-
samine was given to adult DBA (Schmal, Thomas and Konig, 1963), ICR and
C3H mice (Takayama and Oota, 1965), or to pregnant NMRI mice (Mohr and
Althoff, 1965). In particular, mice treated when newborn developed hepatomas
while those treated when adult developed vascular tumours more frequently.
Lung adenomas have been commonly seen in previous as well as in the present
work in both mice treated when adult and newborn.
On the contrary, in none of the strains previously studied, with the possible
exception of C3H mice, was there a consistent production of renal adenomas
comparable to that observed in groups I and II in the present series. Species
and strain differences concerning chemical carcinogenesis are well known in other
experimental systems (Heston, 1965). Inthe case ofDMN-which is believed to be
enzymatically transformed into an active metabolite, probably an alkylating
agent-a correlation between extent of alkylation of cellular components and
carcinogenesis has been observed for several organs of different species (Lee,
Lijinsky and Magee, 1964). However, no data are known about alkylation in
Swiss mice given DMN.
The finding that in less than 24 hours old or a week old mice DMN exerted its
carcinogenicity on the liver and lung but not on the kidney deserves some com-
ments. A direct comparison is impossible since newborn mice received a single
subcutaneous injection of DMN while adults were given the carcinogen in the
drinking water. However, it is remarkable that in the adults an exposure to
DMN as short as 7 days was enough to produce renal adenomas. The absence
of renal tumours in mice given 25 or 37-5 ,ag. DMN when newborn or a week old
contrasts with the concept that newborn rodents are highly susceptible to chemical
carcinogens (Pietra, Spencer and Shubik, 1959; Roe, Rowson and Salaman.
1961; Chieco-Bianchi et al., 1965; O'Gara et al., 1965) and in particular with the
finding that renal tumours can be consistently induced in Wistar-Porton rats by
the administration of 62-5 or 125 jug. DMN/rat at 1 or 7 days of age (Terracini
and Magee, 1964; Terracini and Palestro. unpublished experiments). It isCARCINOGENICITY OF DIMETHYLNITROSAMINE 875
plausible that under the present experimental conditions an ineffective concentra-
tion of the carcinogen was reached in the kidney of newborn mice. This would
suggest a difference either of distribution of DMN and/or its metabolites or of
threshold for renal carcinogenicity between newborn Swiss mice and newborn
Wistar-Porton rats. Since a relation has been suggested between tumour develop-
ment and ability of organs and tissues to metabolize DMN (Lee et al., 1964;
Magee, 1964), a possible working hypothesis is that the kidney of newborn Swiss
mice lacks the ability to metabolize DMN. The present finding is comparable
to the previous observation that no tubular necrosis was produced in newborn
rats with DL-serine at doses which are nephrotoxic for adult rats (Wachstein and
Robinson, 1965; Terracini and Palestro, 1966).
The relation between tubular cysts and renal adenomas is uncertain. The
former type of lesion has been described after irradiation and unilateral nephrec-
tomv in mice (Rosen and Cole, 1962) and following administration of DAIN to
rats (Magee and Barnes, 1962). Both these conditions are carcinogenic and the
cystic lesions have been considered as morphological precursors of the renal
tumours. However, in other studies, tubular hyperplasia was described in
untreated old rats (Allen Durand, Fisher and Adams, 1964; Foley et al., 1964)
and in the present investigation similar changes were found in untreated control
mice which lived their natural lifespan without developing renal adenomas. At
the present time it cannot be stated whether in Swiss mice DMN induces the
renal adenomas since their inception or the neoplastic transformation originates
from tubular changes occurring independently from the administration of DMN.
SUMMARY
(1) Liver vascular tumours, hepatomas and lung adenomas have been induced
with IDMN in Swiss mice treated when adults. Mice treated when newborn
developed hepatomas and lung adenomas. These findings confirm previous
results in other strains of mice.
()) In addition, renal adenomas have been observed in Swiss mice of both
sexes exposed to DMN when adults but not in those injected when newborn or
in untreated controls.
(3) Hyperplastic changes in the renal tubules have been observed in all the
groups including the untreated controls. Their relation to tumour formation in
the kidney is uncertain.
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